Every material Form 8-K Varex Imaging Corp has filed with the SEC since August 10, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Varex Imaging filed supplemental disclosures to its proxy statement for the proposed acquisition by Teledyne Technologies, in response to two shareholder complaints and 13 demand letters that claim the proxy is misleading. The company says the claims are without merit and that the supplements do not change the merger consideration or the timing of the October 28, 2026 special meeting, but the lawsuits seek to block the deal until more information is disclosed.
Two complaints were filed in New York Supreme Court on October 6 and October 7, 2026, and seek to enjoin the merger; the company also received 13 demand letters, one with a draft complaint.
The HSR Act waiting period is set to expire at 11:59 pm Eastern time on November 19, 2026, unless terminated early or extended.
The UK National Security and Investment Act review period runs until November 18, 2026, after the notification was accepted on October 8, 2026.
The special meeting of stockholders to vote on the merger is set for October 28, 2026, at 4:30 p.m. Mountain Time, and the board continues to recommend voting FOR the merger.
Varex Imaging entered into a merger agreement under which Teledyne Technologies will acquire the company, with each Varex share converted into the right to receive $18.90 in cash. The companies put the aggregate transaction value at approximately $1.1 billion, including equity awards and net debt as of April 3, 2026. Closing is expected in early 2027, subject to Varex stockholder approval and regulatory clearances, and the shares would be delisted from Nasdaq if the deal closes.
Cash consideration of $18.90 per share, without interest, subject to tax withholding
Aggregate transaction value of approximately $1.1 billion, per the companies' joint announcement
Expected closing in early 2027, subject to stockholder approval, HSR waiting period expiration and foreign regulatory clearances
Board of Directors of both companies unanimously approved the transaction; no financing condition applies
Varex reported preliminary unaudited third-quarter fiscal 2026 results, with revenue up 4% year over year and GAAP net income of $15.7 million, or $0.37 per diluted share, compared with a loss in the prior-year quarter that included a $93.9 million goodwill impairment. The company will not provide financial guidance and cancelled its earnings call because of the pending transaction with Teledyne Technologies, and it has not yet filed its Form 10-Q, so the results remain subject to change.
Quarterly revenue of $210.5 million for the three months ended July 3, 2026, up from $203.0 million a year earlier.
GAAP diluted EPS of $0.37 versus a loss of $2.15 a year earlier; non-GAAP diluted EPS of $0.31 versus $0.13.
IEEPA tariff refunds of $17 million and a $7 million revenue reduction for customer reimbursements raised third-quarter gross profit by about $10 million.
No financial guidance was provided; the earnings call was cancelled due to the announced Teledyne transaction.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Varex Imaging Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →